Novartis

Assets of former protected witnesses in Novartis Case, “Maximos Sarafis” and “Aikaterini Kelesi,” have been seized Proto Thema News20:29
Here's why Novartis (NVS) is a strong momentum stock Zacks15:54
Why Novartis stock topped the market today The Motley Fool00:53
Novartis axes 550 jobs at Swiss manufacturing site Pharmaceutical Technology17:45
Novartis Korea secures reimbursement for Cosentyx in hidradenitis suppurativa Korea Biomedical Review04:10
Novartis announces plans for new US manufacturing hub PMLiVE12:50
Arrotex appoints former Novartis executive as CEO ShareCafe00:02

Latest News

In the last 5 minutes

Tiny Biotech Terns Takes Aim At Novartis' Leukemia Blockbuster Benzinga13:22

In the last 15 minutes

Novartis ianalumab significantly extends disease control in patients with immune thrombocytopenia with only four… Novartis (Press Release)13:09

In the last hour

1 in 4 metastatic breast cancer patients treated with Novartis Kisqali® remain progression-free beyond 4 years Novartis (Press Release)12:38

In the last 4 hours

Mishcon de Reya advises Relation Therapeutics on strategic multi-programme collaboration with Novartis Mishcon de Reya (Press Release)10:43

Novartis Strikes Deal With UK Biotech for Up To $1.7 Billion (1) Bloomberg Law10:41

Earlier today

Novartis executive urges von der Leyen to ‘walk the talk’ EurActiv.com05:11

Yesterday

STAT Plus: At ASH, Terns looks like rival to Novartis with drug for chronic myeloid leukemia STAT22:07 8-Dec-25

Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment BioPharma Dive19:55 8-Dec-25

STAT Plus: Results in Terns leukemia drug study suggest it could be a successor to Novartis… STAT19:51 8-Dec-25

Breast Cancer Changed My Life But Didn’t Define Me Prevention.com15:59 8-Dec-25

In the last 7 days

Avidity Hit With Suit Aiming to Block $12 Billion Novartis Deal Bloomberg Law01:30 4-Dec-25

Novartis, Marketing Firm Want Out Of Trade Secrets Suit Law36023:11 3-Dec-25

Novartis, Bayer raised to Overweight by Morgan Stanley on valuation appeal Investing.com11:24 3-Dec-25

Arrotex Appoints Former Novartis Executive as CEO ShareCafe00:02 2-Dec-25

In the last month

Colorectal Cancer Market Set to Expand Throughout Forecast Period (2025-2034) Driven by… PR Newswire (Press Release)22:34 1-Dec-25

Progress In Fight Against Malaria, As New Treatment Shows Promise Forbes21:45 1-Dec-25

Protego Biopharma Raises $130 Million Oversubscribed Series B Financing to Advance… PR Newswire (Press Release)11:02 1-Dec-25

US FDA approves Novartis' gene therapy for treatment of spinal muscular atrophy BioSpectrum Asia16:54 28-Nov-25

Novartis’ Itvisma gets FDA approval for spinal muscular atrophy treatment PMLiVE12:15 28-Nov-25

New malaria drug heralds resistance breakthrough SciDev.Net09:29 28-Nov-25

Novartis Korea secures reimbursement for Cosentyx in hidradenitis suppurativa Korea Biomedical Review04:10 28-Nov-25

Assets of former protected witnesses in Novartis Case, “Maximos Sarafis” and “Aikaterini Kelesi,” have been seized Proto Thema News20:29 27-Nov-25

Novartis Case: Assets of 2 Ex-Protected Witnesses Reportedly Frozen To Vima20:02 27-Nov-25

Here's Why Novartis (NVS) is a Strong Momentum Stock Zacks15:54 27-Nov-25

Novartis axes 550 jobs at Swiss manufacturing site Pharmaceutical Technology17:45 26-Nov-25

Cure SMA Welcomes Broad FDA Approval of Itvisma™ for Spinal Muscular Atrophy, Reinforces… PR Newswire (Press Release)17:26 26-Nov-25

Novartis adjusts manufacturing strategy in Switzerland to secure competitiveness European Pharmaceutical Review14:53 26-Nov-25

Novartis announces plans for new US manufacturing hub PMLiVE12:50 26-Nov-25

Why Novartis Stock Topped the Market Today The Motley Fool00:53 26-Nov-25

Novartis’ Itvisma wins US FDA approval for SMA patients ages 2+ BioWorld21:55 25-Nov-25

FDA Greenlights Novartis' Gene Replacement Treatment for SMA Zacks20:06 25-Nov-25

Itvisma Broad Label A Big Boon For Novartis’s SMA Revenues Scrip Pharma Intelligence17:10 25-Nov-25

FDA OKs Novartis SMA Treatment As First Gene Therapy Option For Kids, Teens And Adults Benzinga15:51 25-Nov-25

Novartis scores FDA approval for new version of SMA gene therapy, prices at $2.59M FiercePharma15:38 25-Nov-25

Novartis to cut 550 jobs at plant in Switzerland by end of 2027 FiercePharma15:28 25-Nov-25

STAT Plus: Pharmalittle: We’re reading about a Novo next-gen diabetes drug, a Novartis gene… STAT14:01 25-Nov-25

Novartis cutting up to 550 jobs in northern Switzerland ShareCast12:55 25-Nov-25

FDA gives approval to Novartis' SMA gene replacement therapy Itvisma Manufacturing Chemist12:40 25-Nov-25

Novartis Gains FDA Approval for Groundbreaking SMA Gene Therapy TipRanks11:38 25-Nov-25

Novartis' SMA gene therapy cleared for wider use in US pharmaphorum10:20 25-Nov-25

Novartis secures approval from FDA for Itvisma to treat SMA Pharmaceutical Technology09:12 25-Nov-25

BofA upgrades Novartis and GSK as pivotal data, new launches approach Investing.com09:05 25-Nov-25

Celltrion accelerates Europe rollout of Xolair biosimilar Korea Biomedical Review07:25 25-Nov-25

Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS Novartis (Press Release)06:29 25-Nov-25

US FDA approves Novartis' gene therapy for rare muscle disorder The Economic Times03:00 25-Nov-25

Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, … Novartis (Press Release)22:42 24-Nov-25

Labcorp Appoints Victor Bulto to Board of Directors PR Newswire (Press Release)13:32 24-Nov-25

Georgia to expand oncology drug program with additional USD 18 million Georgia Today11:59 24-Nov-25

Novartis Plans to Build Flagship Manufacturing Hub in North Carolina Genetic Engineering and Biotechnology News18:24 21-Nov-25

Novartis reports primary endpoint reached in phase 3 malaria trial PMLiVE13:11 21-Nov-25

HCMC University Medical Centre, Novartis strengthen collaboration to advance medical innovation and healthcare training … Viet Nam News04:05 21-Nov-25

Novartis Projects Faster Growth Through 2030 After Raising Drug Forecasts Benzinga17:55 20-Nov-25

Novartis Issues Updated Mid-term Sales Guidance; Upgrades Peak Sales Guidance For Kisqali, Scemblix RTT News13:37 20-Nov-25

Novartis announces major NC expansion, 700 jobs across three Triangle sites News & Observer, North Carolina12:35 20-Nov-25

Novartis Projects Strong Growth with Updated Sales Guidance and Strategic Acquisitions TipRanks11:37 20-Nov-25

Novartis To Add Small Molecule & Fill/Finish Capacity With North Carolina Drug Manufacturing… Pharmaceutical Online11:33 20-Nov-25

Novartis taps North Carolina as new manufacturing hub location Pharmaceutical Technology11:25 20-Nov-25

Novartis sees sales boost from key cancer drugs Investing.com10:29 20-Nov-25

Novartis projects +5-6% cc sales CAGR 2025-2030, with long-term growth backed by 30+ potential high-value pipeline… Novartis (Press Release)06:09 20-Nov-25

Novartis picks NC for 700-job expansion Bizjournals01:33 20-Nov-25

Novartis pledges major expansion, 700 new jobs across NC Triangle sites News & Observer, North Carolina19:36 19-Nov-25

Novartis maps out plan for 'flagship' production hub in NC, eyes 700 hires FiercePharma19:36 19-Nov-25

Novartis to build manufacturing hub in North Carolina, creating 700 jobs Yahoo! US18:59 19-Nov-25

Competition Bureau expands its investigation into BWX Technologies’ acquisition of Kinectrics Government of Canada (Press Release)18:22 19-Nov-25

Novartis announces plans to build flagship manufacturing hub in North Carolina Novartis (Press Release)17:36 19-Nov-25

Novartis to Expand U.S. Manufacturing Footprint in Durham and Wake Counties, Adding 700 Jobs with a $771 Million… Office of the North Carolina Governor (Press Release)16:59 19-Nov-25

Novartis Korea cleared to expand Fabhalta indication to adult C3G patients Korea Biomedical Review07:50 19-Nov-25

Novartis’ next-generation malaria treatment GanLum hits Phase III target with 97% cure rate Manufacturing Chemist14:35 17-Nov-25

New malaria treatment holds promise against rising drug resistance News-Medical.Net11:07 17-Nov-25

Novartis announces successful malaria drug trial; Major hope against rising resistance The Week (India)10:04 17-Nov-25

Novartis reveals new drug to fight malaria resistance and transmission AfricaNews19:31 14-Nov-25

Here's Why Novartis (NVS) is a Strong Value Stock Zacks15:45 14-Nov-25

Uganda: Novartis' New Antimalarial Ganlum Offers Hope Against Drug Resistance in Africa AllAfrica07:07 14-Nov-25

With malaria numbers rising, Novartis has phase III success BioWorld22:30 13-Nov-25

Novartis' Investigational Medicine Shows Potent Activity Against Drug-Resistant Malaria Strains Benzinga18:09 13-Nov-25

Novartis' Phase III Malaria Study Meets Key Non-Inferiority Endpoint Zacks15:18 13-Nov-25

Novartis to seek approval of anti-malaria drug on Phase III success Clinical Trials Arena12:12 13-Nov-25

Novartis says novel drug could counter malaria resistance pharmaphorum11:46 13-Nov-25

Novartis Stock (NVS) Doesn’t Suck as it Hails Generational Anti-Malaria Drug TipRanks10:50 13-Nov-25

New Malaria drug from Novartis could tackle growing drug resistance The Financial Express08:28 13-Nov-25

Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoint, with potential… Novartis (Press Release)22:35 12-Nov-25

expert reaction to press release from Novartis about their phase III trial of their next-generation malaria treatment… Science Media Centre22:10 12-Nov-25

Novartis Expands U.S. footprint With New Radioligand Therapy Facility In California Pharmaceutical Online11:48 12-Nov-25

Novartis receives SMC approval for early breast cancer treatment Pharmafile12:26 11-Nov-25

Novartis opens California site for RLT manufacturing Pharmaceutical Technology09:40 11-Nov-25

Novartis opens third US radioligand manufacturing facility European Pharmaceutical Review09:14 11-Nov-25

Novartis Argues For High Court To Skip Entresto Patent Case Law36022:51 10-Nov-25

Novartis opens new radioligand therapy manufacturing facility in California as part of $23B US expansion plan Novartis (Press Release)14:37 10-Nov-25

CCP authorises acquisition of Novartis Pakistan by Iil The Nation03:01 9-Nov-25

International Investment to acquire Novartis Pharma The Express Tribune02:54 9-Nov-25

Phase-I assessment over: CCP clears IIL’s takeover of Novartis Business Recorder, Pakistan22:50 8-Nov-25

CCP authorises IIL’s takeover of Novartis Pakistan Business Recorder, Pakistan15:06 8-Nov-25

view more headlines

9 Dec 13:22

About our Novartis news

Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.

Novartis

Latest News

About our Novartis news

Pharmaceuticals Top Stories

UK Top Stories

World Top Stories